Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haining Ding

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Applied Clinical Medical Physics|January 15, 2026
Development and clinical application of a high-performance medical static computed tomography systemHaining Ding, Yunxiang Li, Zhili Cui, et al.
Cancer Cell International|September 30, 2025
Breast neoplasm epithelial-mesenchymal transition and cytokines: a systematic reviewYian Chen, Haining Ding, Jiaqing Song, et al.
Peerj|June 29, 2026
The multifaceted role of bile acids in breast cancer: pathogenesis, therapeutic potential, and drug deliveryQinghong Yu, Haining Ding, Yi'an Chen, et al.
Frontiers in Pharmacology|June 1, 2026
Konjac petroleum ether extract inhibits triple-negative breast cancer cell migration and invasion by attenuating <i>OLFML2A</i>-mediated epithelial-mesenchymal transitionYian Chen, Qinghong Yu, Haining Ding, et al.
Current Cancer Drug Targets|October 15, 2025
Gut Microbiota: An Innovative Traditional Chinese Medicine Perspective on Breast Cancer TherapyHaining Ding, Yian Chen, Qinghong Yu, et al.
Frontiers in Oncology|January 29, 2026
OLFML2A mediates cell cycle regulation in triple-negative breast cancer via EZH2Haining Ding, Yian Chen, Qinghong Yu, et al.
Molecular and Cellular Biochemistry|August 20, 2025
Characterization of intestinal microbiota in patients with psoriasis combined with metabolic syndromeYiyue Yuan, Linna Zhao, Haining Ding, et al.
Journal of Cutaneous Medicine and Surgery|February 5, 2024
Interleukins and PsoriasisQi Zhu, Linna Zhao, Haining Ding, et al.
Current Cancer Drug Targets|March 6, 2025
Pharmacological Evaluation of Amorphophalli rhizoma to Inhibit the Progression of Estrogen Receptor+ (ER+) Breast Cancer by Modulating the PI3K/AKT Cell Signaling PathwayHailong Li, Qinghong Yu, Jiaqing Song, et al.
Archives of Dermatological Research|August 21, 2021
Clinical efficacy and safety of using calcipotriol-betamethasone compounding agent for psoriasis treatment: a systematic review and meta-analysisJunrong Ren, Qi Zhu, Siyao Wang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Applied Clinical Medical Physics|January 15, 2026
Development and clinical application of a high-performance medical static computed tomography systemHaining Ding, Yunxiang Li, Zhili Cui, et al.
Cancer Cell International|September 30, 2025
Breast neoplasm epithelial-mesenchymal transition and cytokines: a systematic reviewYian Chen, Haining Ding, Jiaqing Song, et al.
Peerj|June 29, 2026
The multifaceted role of bile acids in breast cancer: pathogenesis, therapeutic potential, and drug deliveryQinghong Yu, Haining Ding, Yi'an Chen, et al.
Frontiers in Pharmacology|June 1, 2026
Konjac petroleum ether extract inhibits triple-negative breast cancer cell migration and invasion by attenuating <i>OLFML2A</i>-mediated epithelial-mesenchymal transitionYian Chen, Qinghong Yu, Haining Ding, et al.
Current Cancer Drug Targets|October 15, 2025
Gut Microbiota: An Innovative Traditional Chinese Medicine Perspective on Breast Cancer TherapyHaining Ding, Yian Chen, Qinghong Yu, et al.
Frontiers in Oncology|January 29, 2026
OLFML2A mediates cell cycle regulation in triple-negative breast cancer via EZH2Haining Ding, Yian Chen, Qinghong Yu, et al.
Molecular and Cellular Biochemistry|August 20, 2025
Characterization of intestinal microbiota in patients with psoriasis combined with metabolic syndromeYiyue Yuan, Linna Zhao, Haining Ding, et al.
Journal of Cutaneous Medicine and Surgery|February 5, 2024
Interleukins and PsoriasisQi Zhu, Linna Zhao, Haining Ding, et al.
Current Cancer Drug Targets|March 6, 2025
Pharmacological Evaluation of Amorphophalli rhizoma to Inhibit the Progression of Estrogen Receptor+ (ER+) Breast Cancer by Modulating the PI3K/AKT Cell Signaling PathwayHailong Li, Qinghong Yu, Jiaqing Song, et al.
Archives of Dermatological Research|August 21, 2021
Clinical efficacy and safety of using calcipotriol-betamethasone compounding agent for psoriasis treatment: a systematic review and meta-analysisJunrong Ren, Qi Zhu, Siyao Wang, et al.
Pageof 1